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Introduction 
Sézary syndrome is a rare leukemic subtype of 
cutaneous T cell lymphoma (CTCL) characterized by 
erythroderma, lymphadenopathy, and malignant T 
cells (Sézary cells) in the peripheral blood [1]. 
Although the erythroderma is often accompanied by 
lichenification, keratoderma, nail dystrophy, and 
alopecia, bullous lesions are a rare finding in Sézary 
syndrome [1, 2]. Sézary syndrome can arise in the 
setting of pre-existing mycosis fungoides or as a de 
novo form of T cell lymphoma. Although mycosis 
fungoides is of resident effector memory T cell origin, 
de novo primary Sézary syndrome is derived from 
central memory T cells, showing a characteristic 
expression of PD1 amidst the neoplastic T cells. We 
present a case of bullous Sézary syndrome and 
discuss the prognostic significance of bullous lesions 
in Sézary syndrome and mycosis fungoides. 
 
Case Synopsis 
A 70-year old woman was admitted for pruritic, 
erythematous, edematous plaques with overlying 
flaccid bullae and erosions involving the scalp, neck, 
torso, and extremities (Figure 1). Her rash had been 
slowly progressing over the two months prior to 
admission and was associated with shallow 
ulcerations on the tongue and conjunctival injection. 
She also demonstrated facial skin thickening, 
ectropion, nail changes, and palmar keratoderma. 
She had a history of hypertension, diabetes, and 
hypercholesterolemia and was on medications to 
treat these conditions. There had not been any 
changes to her medications for several months 
preceding her symptoms. A skin biopsy from her 
chest showed a striking pattern of epidermal 
infiltration by neoplastic cells, which were also 
present at the interface between the epidermis and 
papillary dermis resulting in intraepidermal and 
subepidermal bulla formation (Figure 2). Many 
larger neoplastic cells and frequent mitoses were 
identified. Cytologically, neoplastic cells were 
medium-to-large in size with round-to-oval nuclear 
contours and prominent nucleoli. 
Immunophenotypically, these neoplastic cells were 
positive for CD3, CD4, and negative for CD8, CD20, 
CD30, CD34, and CD56. Complete blood count  
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showed a markedly elevated white blood cell count 
at 55.7×103cells/μL with 86% lymphocytes. 
Peripheral blood was analyzed by flow cytometry, 
which showed 88% lymphocytes with a CD4:CD8 
ratio of 232:1. T cells were positive for CD3, CD4, CD5, 
CD25 and negative for CD7, CD8, CD10 and CD56. A 
PET-CT demonstrated increased uptake in bilateral 
neck, axillary, iliac, and inguinal lymph nodes. A 
biopsy of a right axillary lymph node showed 
effacement of normal architecture by innumerable 
medium-to-large cells with prominent nucleoli that 
were positive for CD3, CD4 and negative for CD7, 
CD8, similar to the neoplastic population in the skin. 
T cell gene rearrangement studies performed on 
peripheral blood demonstrated a clonal T cell 
population and cytogenetics also showed changes 
consistent with T cell malignancy. Antibodies to 
human T-cell lymphotropic virus I and II were  
negative. Testing for herpes simplex virus and 
varicella zoster virus from cutaneous lesions by PCR 
was negative. Direct immunofluorescence of 
perilesional skin and serum indirect 
immunofluorescence were negative for 
autoimmune bullous diseases. Given her 
constellation of clinical symptoms, flow cytometry 
analysis, and histology, she was diagnosed with 
bullous Sézary syndrome. She received one cycle of 
cyclophosphamide-doxorubicin-vincristine-
prednisone chemotherapy but she developed 
infectious complications with both urosepsis and 
superinfection of cutaneous lesions. She succumbed 
to her disease less than two months after 
presentation. 
 
Case Discussion 
Bullous lesions are a rare and serious presentation of 
Sézary syndrome and mycosis fungoides. We present 
a 70-year-old woman with Sézary syndrome who 
presented with extensive pruritic flaccid bullae over 
most of her body. At presentation, given the pruritic 
nature of her lesions as well as numerous flaccid 
bullae and oral involvement, autoimmune blistering 
disorders as well as Stevens Johnson syndrome/toxic 
epidermal necrolysis (SJS/TEN) were high on our 
differential diagnosis. Skin biopsies for H&E and 
immunofluorescence as well as blood analysis for 
indirect immunofluorescence conclusively 
demonstrated no evidence of blistering disease and 
also did not support a diagnosis of SJS/TEN. 
Immunohistochemistry as well as peripheral blood 
flow cytometry strongly supported an underlying 
diagnosis of a cutaneous T cell lymphoma. 
Subsequent PET-CT scan showed lymph node 
involvement as well, which was confirmed by biopsy. 
Although a diagnosis of bullous mycosis fungoides 
was also considered, her peripheral blood and lymph 
node involvement along with typical SS clinical 
features of ectropion, thickened facial skin, nail 
changes, and palmar keratoderma favored a 
diagnosis of bullous Sézary syndrome. 
Bullous mycosis fungoides or MF bullosa was first 
characterized by Kaposi in 1887 with fewer than 30 
cases reported in the literature to date [3]. Bullous  
 
Figure 1. Clinical images of bullous Sézary syndrome. A) Right leg 
showing vesicles and bullae superimposed on erythematous, 
edematous plaques. B) Rupture of bullae resulting in erosions on 
right arm. 
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Sézary syndrome is even rarer with fewer than 10 
cases reported. Bullous lesions may arise in existing 
lesions of CTCL or as the initial presentation, may be 
associated with patch, plaque, or tumoral lesions and 
display a predilection for the torso and extremities [2, 
4–11]. Oral mucosal involvement was present in our 
patient and has been described in one other case of 
bullous Sézary syndrome [9]. Both bullous MF and 
Sezary syndrome carry a poor prognosis with almost 
half of patients succumbing to their disease within 
one year [2, 12, 13]. Histology of bullous lesions may 
show an intraepidermal or subepidermal split along 
with features of MF or Sézary syndrome [14]. 
Immunofluorescence studies are necessary to rule 
out various autoimmune bullous disorders including 
pemphigus, pemphigoid, linear IgA, and 
paraneoplastic pemphigus. 
The pathogenesis of intraepidermal and 
subepidermal bullae in Sézary syndrome is unclear, 
but proposed hypotheses include the confluence of 
multiple Pautrier microabscesses resulting in 
intraepidermal vesicles and the disruption of 
keratinocyte-basal lamina attachment by 
epidermotropic lymphocytes resulting in 
subepidermal vesicles [1, 2, 5]. Alternatively, 
lymphokines released by atypical lymphocytes have 
been postulated to be responsible for loss of 
keratinocyte cohesion [3]. In contrast, an 
ultrastructural study found normal keratinocyte-
keratinocyte and keratinocyte-basal lamina cohesion 
and proposed that the formation of bullae may 
instead relate to degeneration of dermal collagen 
induced by neoplastic cells [15]. Notably, a vesicular 
variant of MF has also been described, in which 
clinical findings of weeping, vesicular eczematous 
plaques correspond to histologic findings of 
prominent intercellular edema and intraepidermal 
mucin; this entity exhibits a more aggressive clinical 
course. In contrast to the proposed mechanisms for 
the pathogenesis of bullous SS, vesicular MF has 
been postulated to reflect a transition from a Th1 to 
a Th2 cytokine profile, which includes the 
upregulation of the immunosuppressive cytokine 
IL10 and correlates with disease progression [16]. 
Negative prognostic factors for Sézary syndrome and  
mycosis fungoides include advanced disease stage, 
older age at onset, and large cell transformation [17]. 
In patients with bullous mycosis fungoides, 
approximately 50% died within one year of 
presentation [2, 13]. Of the reported cases of bullous 
Sézary syndrome, two patients passed away within 
one year of presentation and one patient was in 
remission at 15 months although longer term follow-
up was not reported [9–11]. This parallels the disease  
Figure 2. Histopathological images of bullous Sézary syndrome 
of chest biopsy. A) Dense infiltrate of atypical lymphocytes in the 
upper dermis with striking infiltration into the epidermis. Large 
collections of neoplastic cells disrupting the epidermis and 
dermoepidermal junction result in formation of intraepidermal 
and subepidermal bullae. H&E, 400×, B) Morphologically, atypical 
cells are intermediate to large in size with prominent nucleoli, 
H&E, 400×, C) and stain positively for CD3, 400×. 
A
B
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progression of the patient presented in this report, 
further suggesting that although extremely rare, the 
presence of bullous lesions in Sézary syndrome 
portends a poor prognosis. 
 
Conclusion 
This case describes bullous lesions as a rare 
presentation of Sézary syndrome. Although bullous 
lesions in CTCL predominantly occur on the torso 
and extremities as was seen in our patient, oral 
involvement was also present in our case, which  
underscores the importance of distinguishing this 
entity from important conditions in the differential 
diagnosis including SJS/TEN and autoimmune 
blistering disorders. A majority of these patients died 
within one year from presentation. These findings 
suggest that the development of bullous lesions in 
cutaneous T cell lymphoma may be associated with 
a poorer prognosis. 
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